Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities:
Net loss	$ (1,042,092)	$ (2,222,663)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation	1,362,934	1,322,000
Amortization of debt issuance costs	35,526	35,525
Stock based compensation expense related to issuance of restricted stock	3,900	3,900
Discontinued operating activities		402,187
Increase (decrease) in cash, cash equivalents, and restricted cash from changes in assets and liabilities:
Other assets	81,519	(15,446)
Accounts payable and accrued liabilities	291,074	198,336
Due to affiliates	152,744	678,838
Discontinued operating activities - changes in assets and liabilities		113,750
Net cash provided by operating activities	885,605	516,427
Cash flows from investing activities:
Additions to real estate	(397,189)	(272,483)
Discontinued investing activities		(59,180)
Net cash used in investing activities	(397,189)	(331,663)
Cash flows from financing activities:
Scheduled principal payments of mortgage loans	(471,311)	(435,073)
Discontinued financing activities		(319,866)
Net cash used in financing activities	(471,311)	(754,939)
Net change in cash, cash equivalents, and restricted cash	17,105	(570,175)
Cash, cash equivalents, and restricted cash, beginning of period	11,976,151	8,288,459
Cash, cash equivalents, and restricted cash, end of period	11,993,256	7,718,284
Supplemental disclosures and non-cash transactions:
Cash paid for interest - continuing and discontinued operations	1,290,900	2,252,820
Debt issuance costs in accounts payable and accrued liabilities		48,736
Distributions payable to preferred unit holders in our Operating Partnership	$ 364,653	$ 347,582